Amplifon (AMFPF)
(Delayed Data from OTC)
$35.00 USD
0.00 (0.00%)
Updated May 17, 2024 09:38 AM ET
4-Sell of 5 4
C Value B Growth B Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
AMFPF 35.00 0.00(0.00%)
Will AMFPF be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for AMFPF based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AMFPF
Is GoodRx (GDRX) Outperforming Other Medical Stocks This Year?
Is Aadi Bioscience (AADI) Stock Outpacing Its Medical Peers This Year?
AMFPF: What are Zacks experts saying now?
Zacks Private Portfolio Services
All You Need to Know About Amplifon S.p.A. (AMFPF) Rating Upgrade to Buy
Is Aadi Bioscience (AADI) Outperforming Other Medical Stocks This Year?
New Strong Sell Stocks for January 16th
Other News for AMFPF
Amplifon price target raised by EUR 3 at Barclays
Amplifon S.p.A. (AMFPF) Q1 2024 Earnings Call Transcript
Amplifon price target raised by EUR 1 at Morgan Stanley
Amplifon price target lowered by EUR 1.60 at JPMorgan
Kepler Cheuvreux gets more bullish on Amplifon, upgrades shares